GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Derma Sciences, Inc. (DSCI) [hlAlert]

Rating:
Outperform
DSCI
down 40.00 %

Derma Sciences, Inc. (DSCI) rated Outperform with price target $7 by Oppenheimer

Posted on: Friday,  Jan 8, 2016  9:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Derma Sciences, Inc. (NASDAQ: DSCI) on 01/08/2016. Previously Oppenheimer rated Outperform Derma Sciences, Inc. (NASDAQ: DSCI) on 07/06/2011.,
when the stock price was $9.85. Since then, Derma Sciences, Inc. has lost 40.00% as of 01/08/2016's recent price of $5.91.
If you would have followed the previous Oppenheimer's recommendation on DSCI, you would have lost 40% of your investment in 1647 days.

Derma Sciences, Inc. (Derma Sciences) engages in the manufacture, marketing, and sale of three dermatological related product lines: wound care, wound closure, and specialty securement devices and skin care. In addition, the Company has leveraged its expanding manufacturing capabilities by building a growing private label/original equipment manufacture (OEM) business. The Company?s customers consist of various health care agencies and institutions, such as nursing homes, hospitals, home healthcare agencies, physician?s offices, and retail and closed door pharmacies. It markets its products principally through independent distributors servicing the long-term care, home health, and acute care markets in the United States, Canada, and other select international markets. The Company conducts its business operations primarily through its subsidiaries: Sunshine Products, Inc., Derma Sciences Canada Inc., and Derma First Aid Products, Inc.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2016 9:25 AM Buy
None
3.77 7.00
as of 8/27/2015
1 Week down  -10.45 %
1 Month down  -22.23 %
3 Months down  -15.69 %
1 YTD down  -45.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/13/2015 10:25 AM Buy
None
4.01 8.00
3/17/2014 8:25 AM Buy
None
13.29 21.00
7/6/2011 8:25 AM Buy
None
9.85 21.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy